Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Bardoxolone methyl and kidney function in CKD with type 2 diabetes.
N Engl J Med. 2011 Jul 28;365(4):327-36. doi: 10.1056/NEJMoa1105351. Epub 2011 Jun 24.
N Engl J Med. 2011.
PMID: 21699484
Free article.
Clinical Trial.
Bardoxolone methyl, an oral antioxidant inflammation modulator, has shown efficacy in patients with CKD and type 2 diabetes in short-term studies, but longer-term effects and dose response have not been determined. ...
Bardoxolone methyl, an oral antioxidant inflammation modulator, has shown efficacy in patients with CKD and type 2 diabetes in short-term …
Outcome analysis of mandibular condylar replacements in tumor and trauma reconstruction: a prospective analysis of 131 cases with long-term follow-up.
Marx RE, Cillo JE Jr, Broumand V, Ulloa JJ.
Marx RE, et al. Among authors: broumand v.
J Oral Maxillofac Surg. 2008 Dec;66(12):2515-23. doi: 10.1016/j.joms.2007.12.005.
J Oral Maxillofac Surg. 2008.
PMID: 19022132
Previous investigations into alloplastic mandibular condylar replacement have met with mixed results because they reported only a limited number of patients with short-term follow-up. This investigation sought to determine the long-term outcome of alloplastic replac …
Previous investigations into alloplastic mandibular condylar replacement have met with mixed results because they reported only a limited nu …
Item in Clipboard
Cite
Cite